Sensitivity of mycobacterium leprae to telacebec
The treatment of leprosy is long and complex, benefiting from the development of sterilizing, rapidly-acting drugs. Reductive evolution made Mycobacterium leprae exquisitely sensitive to Telacebec, a phase 2 drug candidate for tuberculosis. The unprecedented potency of Telacebec against M. leprae wa...
Saved in:
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/160139 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
id |
sg-ntu-dr.10356-160139 |
---|---|
record_format |
dspace |
spelling |
sg-ntu-dr.10356-1601392023-03-05T16:52:19Z Sensitivity of mycobacterium leprae to telacebec Lahiri, Ramanuj Adams, Linda B. Thomas, Sangeeta Susan Pethe, Kevin Lee Kong Chian School of Medicine (LKCMedicine) Science::Medicine Leprosy Telacebec The treatment of leprosy is long and complex, benefiting from the development of sterilizing, rapidly-acting drugs. Reductive evolution made Mycobacterium leprae exquisitely sensitive to Telacebec, a phase 2 drug candidate for tuberculosis. The unprecedented potency of Telacebec against M. leprae warrants further validation in clinical trials. Nanyang Technological University National Research Foundation (NRF) Published version This work was supported in part by the Lee Kong Chian School of Medicine, Nanyang Technological University Start-Up Grant (K.P.), the National Research Foundation, Singapore, under its Investigatorship Programme (grant no. NRF-NRFI06-2020-0004), and the New York Community Trust Heiser Program (grant no. P18-000248). US National Institute of Allergy and Infectious Diseases funded the provision of viable M. leprae through an interagency agreement with Health Resources and Services Administration, Healthcare Systems Bureau, National Hansen’s Disease Program (no. AAI20009-001-00000). 2022-07-13T06:41:50Z 2022-07-13T06:41:50Z 2022 Journal Article Lahiri, R., Adams, L. B., Thomas, S. S. & Pethe, K. (2022). Sensitivity of mycobacterium leprae to telacebec. Emerging Infectious Diseases, 28(3), 749-751. https://dx.doi.org/10.3201/eid2803.210394 1080-6040 https://hdl.handle.net/10356/160139 10.3201/eid2803.210394 35202539 2-s2.0-85125256543 3 28 749 751 en NRF-NRFI06-2020-0004 Emerging Infectious Diseases 2022 Public domain. Published by the Centers for Disease Control and Prevention (CDC), a U.S. Government agency. This is an open-access article distributed under the terms of the Creative Commons Attribution License. application/pdf |
institution |
Nanyang Technological University |
building |
NTU Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NTU Library |
collection |
DR-NTU |
language |
English |
topic |
Science::Medicine Leprosy Telacebec |
spellingShingle |
Science::Medicine Leprosy Telacebec Lahiri, Ramanuj Adams, Linda B. Thomas, Sangeeta Susan Pethe, Kevin Sensitivity of mycobacterium leprae to telacebec |
description |
The treatment of leprosy is long and complex, benefiting from the development of sterilizing, rapidly-acting drugs. Reductive evolution made Mycobacterium leprae exquisitely sensitive to Telacebec, a phase 2 drug candidate for tuberculosis. The unprecedented potency of Telacebec against M. leprae warrants further validation in clinical trials. |
author2 |
Lee Kong Chian School of Medicine (LKCMedicine) |
author_facet |
Lee Kong Chian School of Medicine (LKCMedicine) Lahiri, Ramanuj Adams, Linda B. Thomas, Sangeeta Susan Pethe, Kevin |
format |
Article |
author |
Lahiri, Ramanuj Adams, Linda B. Thomas, Sangeeta Susan Pethe, Kevin |
author_sort |
Lahiri, Ramanuj |
title |
Sensitivity of mycobacterium leprae to telacebec |
title_short |
Sensitivity of mycobacterium leprae to telacebec |
title_full |
Sensitivity of mycobacterium leprae to telacebec |
title_fullStr |
Sensitivity of mycobacterium leprae to telacebec |
title_full_unstemmed |
Sensitivity of mycobacterium leprae to telacebec |
title_sort |
sensitivity of mycobacterium leprae to telacebec |
publishDate |
2022 |
url |
https://hdl.handle.net/10356/160139 |
_version_ |
1759856457516318720 |